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ABSTRACT 
 
Aims  
To examine whether norms towards nicotine vaping product (NVP) use varied between 
Australia, Canada, England and the United States and by sociodemographics, smoking and 
NVP status.  
 
Design 
Cross-sectional data from the 2016 ITC Four Country Smoking and Vaping Survey. 
 
Setting 
Four countries with distinct regulatory policies relating to the sale and advertising of NVPs: 
Australia (most restrictive), Canada (restrictive), England and United States (least restrictive).  
 
Participants 
10,900 adult (age 18+) current smokers, former smokers, or at least weekly NVP users. 
Respondents were from Australia (n=1,366), Canada (n=3,309), England (n=3,835) and the 
United States (n=2,390).  
 
Measurements  
Questions permitted the categorization of respondents as current smokers, former smokers, 
NVP users and sociodemographic categories (sex, age, country, ethnicity, income and 
education). Further questions were asked regarding the frequency of exposure to NVPs in 
public, whether they had a partner or close friends who vaped and whether they believed 
society or those considered important to them approved of NVPs. 
 
Findings 
Adjusting for relevant covariates, compared to Australian respondents, those in England, 
Canada and United States were more likely to report frequent exposure to NVPs in public 
(83.1%, 57.3% and 48.3% respectively, compared to 19.8% in Australia; p<0.0001), having a 
partner who vaped (13.8%, 7.1% and 7.7% respectively, compared to 2.1% in Australia; 
p<0.0001) and having close friend(s) who vaped (31.7%, 25.3%, 20.9% respectively, 
compared to 10.0% in Australia; p<0.0001). Compared to Australian respondents, 
respondents from England were more likely to report that society (27.6% , compared to 
12.3% in Australia; p<0.0001) and people important to them approved of NVP use  (28.9% 
compared to 14.3% in Australia; p<0.0001). 
 
Conclusions 
Our findings suggest that norms towards NVP use vary within distinct regulatory contexts. 
Country differences in norms towards NVP use may also reflect differences in NVP 
messaging communicated by prominent health organizations and media outlets.  
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BACKGROUND 
Nicotine Vaping Products (NVPs) are quickly rising in popularity in many countries, 
resulting in considerable discussion about how to regulate these products (1,2). On the one 
hand, some have advocated for the use of NVPs as part of a harm reduction strategy, 
particularly among adult smokers, given the evidence that NVPs are considerably safer than 
combustible cigarettes (3,4). In contrast, others have noted the unknown long-term effects of 
NVPs and raised concerns that NVPs may promote smoking uptake among youth, thus 
undermining tobacco control efforts that have sought to de-normalize smoking behaviours (5–
8).  
Various studies to date have examined the role of smoking norms in predicting smoking 
behaviours (9–14). However, less research has focused on examining social norms towards 
NVPs. Norms can be conceptually divided into descriptive and injunctive norms (15–17). 
Descriptive norms refer to beliefs about the prevalence of a behaviour (e.g., perceptions of 
number of close friends who vape) (15). Injunctive norms refer to beliefs about whether the 
behaviours are considered acceptable by others (e.g., percieved acceptability of vaping) (15). 
Recent research has shown that NVPs are viewed as more socially acceptable than cigarettes 
by youth and young adults (18,19). Specifically, individuals who reported quitting smoking, 
using NVPs, and believing that vaping was less harmful than cigarette use were more likely to 
hold positive norms towards NVP use (20).  
The NVP regulatory environment is expected to restrict specific behaviours and 
communicate messages about societal norms towards NVP use, as suggested by the Theory 
of Triadic Influence (TTI) (21). In this way, the NVP regulatory environment may influence 
attitudes and subsequent norms towards NVPs (21). However, recent studies examining 
social norms towards NVPs across different policy environments have yielded mixed 
findings (20,22). A recent ITC study (International Tobacco Control Survey) using data from 
2014 found that adult current and former smokers from England (less restrictive policy 
environment) were more likely to view NVPs as socially acceptable, compared to their 
counterparts in Australia (more restrictive NVP policy environment) (20). In contrast, a 
recent evaluation of adult current smokers in seven European countries found that public 
approval of NVP use did not align with country-level policies and prevalence rates. (22). 
Apart from these two studies, no other studies to date have conducted cross-country 
comparisons to evaluate differences in social norms towards NVPs as a function of varying 
regulatory contexts. 
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Currently, the debate around NVPs has resulted in countries adopting distinct 
regulatory policies. For instance, Canada had very restrictive policies that prevented the sale 
and marketing of NVPs during the time of the study. Recently, Canada regulated the sale and 
marketing of NVPs through the Tobacco and Vaping Products Act (TVPA), which included 
measures to ban the sale of NVPs to minors and restrictions on marketing considered appealing 
to youth (23). Australia has had very restrictive regulations,which have been more strictly 
enforced than Canada’s regulations (24), whereby NVPs could not be legally sold and could 
only be acquired through a doctor’s prescription (25). In contrast to Canada and Australia, the 
United States and England have had fewer regulations on the sale and marketing of NVPs. 
Within the United States, the sale and advertising of NVPs was permitted through all channels 
during the time of the study. In England, local advertising of NVPs was permitted through a 
number of channels including billboards, posters and point-of-sale. Furthermore, under the 
Tobacco and Related Products Regulations, NVPs were regulated as consumer products and 
subject to minimum standards to ensure the safety and quality of all NVPs (26). 
 The objective of this study was to examine if descriptive and injunctive norms towards 
NVPs differed among current smokers, former smokers and NVP users across Australia, 
Canada, England and United States. We also examined whether these norms varied by 
sociodemographics, smoking and NVP status.  
 
METHODS 
 
Sample Design and Participants  
The ITC Four Country Smoking and Vaping Survey Wave 1 (4CV1) sample was an expansion 
of the ITC Four Country (ITC 4C) Survey and involved harmonized data collection in Australia, 
England, the United States and Canada between July and November 2016 (27,28). The analytic 
sample consisted of : (1) re-contacted smokers and quitters who participated in the previous 
wave of the ITC 4C Project; (2) newly recruited current smokers and recent quitters (i.e., quit 
≤2 years) from country-specific panels, and (3) newly recruited NVP users (at least weekly) 
from country-specific panels. The sample in each country was designed to be representative of 
cigarette smokers, former smokers and NVP users. Individuals were recruited via random-
digit-dialling (RDD) sampling frames, web-based or address-based panels, or a combination 
of these frames. Additional details regarding the methods used can be found elsewhere (28). 
For the current study, all respondents who reported being unaware of NVPs (n=82) , reported 
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being never smokers (n=54) or had missing data for any covariates (described below) were 
excluded, resulting in an analytic sample of 10,900 individuals. 
 
Outcome Measures  
 
Descriptive Norms  
 
Frequency of exposure to NVP use in public 
Participants were asked ‘In the last 30 days, how often, if at all, have you seen anyone vaping 
(using e-cigarettes) in public?’ Responses were classified as  frequent exposure (‘every day’, 
‘most days’ or ‘some days’) versus infrequent exposure (‘rarely’ or ‘not at all’). Participants 
who responded don’t know (n=191) or refused to answer (n=14) were excluded from analyses. 
 
NVP use amongst friend(s) 
Participants were asked (1) ‘How many friends or acquaintances do you spend time with on a 
regular basis?’ Depending on the number [X] of friends respondents reported having , they 
were further asked (2) ‘Of the [X] friends or acquaintances that you spend time with on a 
regular basis, how many of them use e-cigarettes/vaping devices?’ Responses were classified 
as binary responses : at least one friend versus none, due to the small percentage of participants 
who reported having more than one friend who used NVPs. Participants who refused to answer 
(n=80) or responded don’t know (n=599) were excluded from analyses. 
 
Partner NVP use 
Participants were asked (1) ‘Do you currently live with a partner or spouse?’ Those who 
reported having a partner were further asked (2) ‘Does your partner or spouse currently use e-
cigarettes/ vaping devices?’ Responses were categorized as binary responses: Partner uses 
versus partner does not use NVPs. Participants who responded don’t know or refused to answer 
(n=9) were excluded from analyses.  
 
Injunctive Norms  
 
Perceived societal approval of NVP use 
Participants were asked ‘What do you think the general public's attitude is towards vaping/ 
using e-cigarettes?’ Responses were classified into three categories : society approves of NVP 
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use (‘strongly approves’ or ‘somewhat approves’), society does not approve of NVP use 
(‘neither approves or disapproves’, ‘somewhat disapproves’ or ‘strongly disapproves’), or 
don’t know.  Participants who refused to answer (n=14) were excluded from analyses.  
 
Perceived approval of NVP use by those important to the participant  
Participants were asked ‘What do/would people who are important to you think about you 
using e-cigarettes/ vaping devices?’ Responses were classified into three categories: approves 
of NVP use (‘strongly approve’ or ‘somewhat approve’), does not approve of NVP use (‘neither 
approves nor disapproves’, ‘somewhat disapproves’ or ‘strongly disapproves’), or don’t know. 
Participants who refused to answer (n=30) were excluded from analyses.   
 
Predictors  
Sociodemographics 
The following sociodemographics were included in analyses: country (Australia, Canada, 
England or United States) , age (18-24, 25-39, 40-54 or 55+), sex (female, male), ethnicity 
(majority, minority), income (high, medium, low, No information), and education (high, 
medium, low). Categorization of ethnicity, income and education was consistent with previous 
ITC manuscripts (29–31). 
 
Smoking and vaping behaviours  
Two smoking related variables were included in analyses: smoking status (daily smoker, less 
than daily smoker, recently quit [quit ≤2 years] , long term quitter [quit >2 years]), and NVP 
use status (daily use , less than daily use, quit using [at least weekly previous user], tried using 
[once/occasionally], never used).  
 
ANALYSIS 
Descriptive statistics were used to examine the characteristics of respondents within the 
unweighted and weighted sample. Chi squared (X2) tests were used to examine whether country 
samples differed by sociodemographics, smoking and NVP use status.  
Three weighted binary logistic regression models were used to examine country 
differences in: (1) perceived exposure to NVP use in public (frequent vs. non-frequent 
[reference group]); (2) vaping status of partner [conditional upon having a partner; N=6,106], 
and (3) vaping status of close friends [conditional upon having at least one close friend; 
N=9,307].  
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Two weighted multinomial logistic regression models were used to examine country 
differences in: (1) societal approval of NVP use (approves vs. disapproves of NVPs [reference 
group]/ I don’t know vs. disapproves of NVPs [reference group]); and (2) approval of NVP use 
by those important to participant (approves vs. disapproves of NVP use [reference group]/I 
don’t know vs. disapproves of NVPs [reference group]/). ‘I don’t know’ was retained as a 
separate category within these two models due to the large proportion of respondents who 
chose this response option.  
After testing for the main effects in each of the models described above, interactions 
were tested using the method described by Jaccard (2001) to determine whether the relationship 
between NVP use status and each of the five norms examined, differed across countries (32).  
All models adjusted for sociodemographics, smoking status and NVP use status. 
Sample weights were constructed based on population-level estimates of NVP and cigarette 
use derived from national surveys (33). Furthermore, the sampling design was accounted for 
in all models. All analyses were conducted using SAS 9.4.  
 
RESULTS  
Sample Characteristics  
Table 1 presents the sociodemographics and smoking/NVP use status of the unweighted sample 
by country (N=10,900). The findings demonstrated evidence of differences present in 
sociodemographics, smoking status and NVP use status between Australia, Canada, England 
and United States (p<0.0001). Supplementary Table 1 presents characteristics of the weighted 
sample by country (N=10,900).  
 
Descriptive Norms 
 
Exposure to NVP use in public  
After adjusting for sociodemographics and smoking/NVP use status, respondents from 
England were more likely to  report frequent exposure to NVP use in the last 30 days, compared 
with respondents in any other country; the most pronounced differences were seen between 
respondents in England versus Australia (Table 2; AOR= 20.09, p<0.0001). Compared with 
respondents from Australia and the United States (US), Canadian respondents were more likely 
to report frequent exposure to NVP use in public; greater differences were reported between 
Canadian and Australian respondents (AOR=5.39, p<0.0001). Multivariate models also 
showed that males, younger respondents and those with a medium/high household income were 
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more likely to report frequent exposure to NVP use in public (Table 2). Compared to never 
users, those who had any experience using NVPs were more likely to report frequent exposure 
to NVP use in public.   
 
NVP use among close friend(s) 
After adjusting for relevant correlates, respondents in England were more likely to report 
having at least one friend who used NVPs compared to respondents from any other country; 
the largest differences were observed between England and Australia (Table 2; AOR=2.92, 
p<0.0001). Compared with Australian respondents, Canadian respondents were more likely to 
report having at least one friend who used NVPs (AOR=2.30, p<0.0001). Compared with 
Australian respondents , US respondents were more likely to report having at least one friend 
who used NVPs (AOR=1.98, p<0.0001). Multivariate models also showed that younger 
individuals and those with a medium education (vs. low) were more likely to report having at 
least one friend who used NVPs. Compared to long-term quitters, less than daily and daily 
smokers were less likely to report having close friends that used NVPs.  
 
Partner NVP use status 
After adjusting for sociodemographics and NVP/smoking status, respondents in England were 
more likely to report having a partner who used NVPs, compared to any other country; the 
largest differences observed were between England and Australia (Table 2; AOR=4.35, 
p<0.0001). Compared to Australian respondents, Canadian respondents were more likely to 
report having a partner who used NVPs (AOR=2.72, p=0.005). Compared to Australian 
respondents, US respondents were more likely to report having a partner who used NVPs 
(AOR=2.44, p=0.014). Multivariate models also indicated that females and those between the 
age of 25-39 (vs. 55+) were more likely to report having a partner that uses NVPs. Compared 
to never users, respondents who reported any level of experience with NVPs were more likely 
to report having a partner that vaped, with daily vapers having the greatest odds (AOR=36.2 , 
p<0.0001).  
 
Injunctive norms 
 
Perceiving that society approved of NVP use 
After adjusting for relevant correlates, respondents in England were more likely to report that 
society approved of NVP use, compared to any other country; the most pronounced differences 
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were observed between England and Australia (Table 3; AOR=2.10, p<0.0001). Compared to 
Australian respondents, Canadian respondents were more likely to perceive that society 
approved of NVP use (AOR=1.37, p=0.04). Multivariate models also showed that younger 
respondents and ethnic minorities were more likely to perceive that society approved of NVP 
use. Respondents with a medium education were less likely to perceive that society approved 
of NVP use, compared to those with a low education.Compared to never users of NVPs, those 
who reported daily use, less than daily use or having quit were more likely to perceive that 
society approved of NVP use.  
 
Percieving that those important to you approve of NVP use  
After adjusting for sociodemographics and smoking/NVP use status, respondents in England 
were more likely to percieve that people important to them approved of NVP use, compared to 
respondents from any other country. Multivariate models also showed that respondents with a 
high household income and medium/high education were less likely to perceive that people 
important to them approved of NVP use. Daily smokers and individuals who reported any 
previous experience using NVPs were more likely to perceive that people important to them 
approved of NVP use.  
 
Interactions between NVP use and country  
Interactions were tested to examine whether the association between NVP use and the five 
norms examined differed by country. These analyses adjusted for the multiple comparisons 
conducted through the use of the Bonferroni correction. No significant interactions were 
observed between NVP use and country for each of the five norms examined.  
 
DISCUSSION   
 
The results demonstrated systematic differences between respondents in Australia, 
Canada, United States and England for all five norms examined. Within the study sample, a 
sequential gradient was observed whereby respondents from England displayed the most 
positive social norms, followed by Canada and the United States, with Australia displaying the 
least positive norms. With respect to the descriptive norms examined within our study,  the 
greatest level of cross-country variability was observed in the prevalence of perceived exposure 
to NVP use in public, which ranged from 20-83%. In contrast, less pronounced country 
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differences were observed when examining injunctive norms towards NVP use, including 
perceived approval of NVP use by society and those considered important to the participant. 
When examining descriptive norms, respondents from England had over twenty times 
the odds of reporting frequent exposure to NVP use in public, compared to Australian 
respondents. These findings are likely due to the greater prevalence of NVP use within England 
versus Australia(20). Another plausible explanation is that less restrictive regulatory 
environments may facilitate greater opportunities to use NVPs in public (21). In conjunction 
with previous work demonstrating that the trial and use of NVPs may be influenced by distinct 
regulatory contexts (1,2), our findings suggest that NVP regulations may be associated with 
norms towards NVP use.  
With respect to injunctive norms, respondents from England were more likely to report 
that society approved of NVP use, compared to Australian respondents. However, no 
differences in the perceived societal approval of NVP use were observed between Australia 
(more restrictive policy environment) and United States (less restrictive policy environment). 
Similarly, no differences were reported in perceived approval of NVP use by those considered 
important to the participant between Australia, US and Canada. These discrepancies may be 
attributable to other contextual factors, aside from the regulatory environment, influencing 
norms towards NVP use. When considering the US context, media reporting by dominant US 
news agencies has generally cast a negative light on NVP use in recent years; this type of 
messaging may have played a role in shaping perceptions of societal approval of NVP use 
among US respondents (34–36). This is quite different from the  context in England, where 
public endorsements of NVP use from multiple prominent health organizations has resulted in 
more consistent and positive messaging around NVPs (37–39); this is likely to have generated 
positive perceptions of NVP use within England.  
Our findings appear to suggest that distinct regulatory environments may have had an 
influence on levels of uncertainty about the acceptability of NVP use. For instance, Australian 
respondents were more likely to report not knowing whether society approved of NVP use, 
compared to respondents from England (30.7% vs. 11.5%). These findings were consistent 
with prior research demonstrating differences in levels of certainty around the social 
acceptability of NVP use among respondents from Australia versus England (20,40).The 
greater level of uncertainty reported by Australian respondents may be the result of relatively 
lower levels of public engagement within Australia and lower exposure to NVP use , given its 
highly restrictive NVP regulatory environment (40). This suggests that differences observed 
may be a consequence of limited access to information , lower levels of NVP awareness and 
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experience. The uncertainty around the social acceptability of NVP use may also be the result 
of ongoing public discussions about NVPs within various countries. 
Our findings showed that individuals that reported having any level of experience with 
NVPs were consistently more likely to report positive descriptive and injunctive norms towards 
NVP use, compared to never users; specifically, a dose-response association was observed 
between NVP use and all five measures of social norms examined. Extensive research to date 
has demonstrated the role of social norms in predicting smoking behaviours (9–14). For 
instance, prior work has demonstrated how shifts in attitudes and public perceptions of smoking 
within the 1960s ultimately led to declines in smoking behaviour within the United States (12). 
Our findings appear to suggest that similar social processes may be in effect with respect to 
NVPs. In other words, observing social cues from a partner, and/or close friends that engage 
in NVP use may play a role in influencing NVP use. However, given the cross-sectional nature 
of this study which limits our ability to assess the directionality of these associations, we cannot 
test this theory. Furthermore, given the limited evidence to date examining the potential 
influence of social norms towards NVP use on subsequent NVP use, additional longitudinal 
studies are needed to explore this relationship. 
With respect to socio-demographics, younger age groups were more likely to report 
positive norms towards NVP use. This may be explained by the higher prevalence of NVP use 
among younger populations (41–43). They may also reflect the greater adoption of new 
technologies by younger individuals (34). Interestingly, individuals with higher 
income/education levels were more likely to perceive that those important to them disapproved 
of NVP use; these findings may reflect differences in social circles among low versus high SES 
groups. Prior work has shown that low SES groups are more likely to report having a greater 
number of smoking friends; differences in the composition of social networks among low 
versus high SES groups may influence injunctive norms towards NVP use (44).  
 
Study strengths and limitations 
The strengths of the study included the use of data from four countries with divergent NVP 
policy environments, thus providing a more definitive evaluation of associations between 
differing regulatory contexts and norms towards NVP use. Furthermore, the study used data 
from large nationally representative samples. Our study was also subject to various limitations. 
First, we relied on cross-sectional data; thus, the directionality of associations examined cannot 
be established from our study findings. The study also relied on self-reported data which may 
be subject to social desirability bias, resulting in under-reporting of smoking or NVP use (45). 
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Lastly, the analytic sample did not include never smokers and was solely comprised of smokers 
and quitters; current smokers have generally been shown to perceive greater social 
acceptability of NVPs, when compared to non-smokers (46). As such, our findings may not 
generalize to non-smokers.  
 
CONCLUSION  
This study demonstrated variability in norms towards NVP use across Australia, Canada, 
England and the United States.These findings appear to be largely attributable to differences 
in the regulatory environment. They may also reflect differences in messaging around NVP 
use communicated by public health organizations and media outlets. Moving forward, 
additional work is needed to assess how distinct norms towards NVP use may influence the 
subsequent use of NVPs and combustible cigarettes. 
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Table 1: Sample characteristics, N=10,900  
Variables Australiaa, 
N=1,366 
(13%) 
Canadaa, 
N=3,309 
(30%) 
Englanda, 
N=3,835 
(35%) 
USa, 
N= 2,390 
(22%) 
 
p-valueb 
Demographics 
  N (%) N (%) N (%) N (%)  
Sex Female 663 48.5 1,761 53.2 1,813 47.3 1,154 48.3 <0.0001 
Male 703 51.5 1,548 46.8 2,022 52.7 1,236 51.7 
Age 18-24 40 2.9 744 22.5 780 20.3 445 18.6 <0.0001 
25-39 257 18.8 834 25.2 941 24.5 630 26.4 
40-54 526 38.5 925 28.0 1,038 27.1 421 17.6 
55+ 543 39.8 806 24.3 1,076 28.1 894 37.4 
Ethnicity Majority 1,228 89.9 2,730 82.5 3,586 93.6 1,904 79.7 <0.0001 
Minority 138 10.1 579 17.5 247 6.4 486 20.3 
Income Low 276 20.2 710 21.4 783 20.4 723 30.3 <0.0001 
Medium 337 24.7 932 28.2 1,126 29.4 703 29.4 
High 663 48.5 1,443 43.6 1,635 42.6 942 39.4 
Missing Information 90 6.6 224 6.8 291 7.6 22 0.9 
Education Low 457 33.5 942 28.5 1,091 28.5 740 31.0 <0.0001 
Medium 548 40.1 1,502 45.4 1,559 40.7 890 37.2 
High 361 26.4 865 26.1 1,185 30.9 760 31.8 
Participant Smoking & NVP Status 
Smoking 
Status 
Daily use 1,096 80.2 1,992 60.2 2,553 66.6 1,637 68.5 <0.0001 
Less than daily use 116 8.5 874 26.4 882 23.0 395 16.5 
Recently Quit 141 10.3 343 10.4 312 8.1 202 8.5 
Long Term Quit 13 1.0 100 3.0 88 2.3 156 6.5 
NVP  use 
status 
Daily use 109 8.0 341 10.3 550 14.3 523 21.8 <0.0001 
Less than daily use 246 18.0 1447 43.7 1,414 36.9 713 29.8 
Quit using 149 10.9 249 7.5 403 10.5 272 11.4 
Previously Tried 179 13.1 321 9.7 389 10.1 307 12.9 
Never used 683 50.0 951 28.8 1,097 28.2 575 24.1 
a Percentages are based on unweighted data.  
b p-values based on Chi-squared tests. 
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Table 2: Logistic regression assessing correlates of frequency of exposure to NVP use in public in last 30 days, NVP use among close friend(s) and partner use of NVPs 
   
Frequent exposure to NVP use in public 
(N=10,900) 
 
NVP use among close friend(s) 
(N=9,307)a 
 
 
 
Partner uses NVPs 
(N=6,106)b 
  % AOR (95% CI) 
 
p-value  % AOR (95% CI) p-value  % AOR (95% CI) p-value 
Country Australia 19.8 Ref. -- 10.0 Ref. -- 2.1 Ref. -- 
 Canada 57.3 5.39 (4.20– 6.92) <0.0001 25.3 2.30 (1.67- 3.15) <0.0001 7.1 2.72 (1.36-5.42) 0.005 
 England 83.1 20.09 (15.47 – 26.12) <0.0001 31.7 2.92 (2.13- 4.00) <0.0001 13.8 4.35 (2.19-8.62) <0.0001 
 United States 48.3 4.04 (3.09 – 5.27) <0.0001 20.9 1.98 (1.41-2.78) <0.0001 7.7 2.44 (1.19-4.98) 0.014 
Sex Female 43.1 Ref. -- 22.8 Ref. -- 10.7 Ref. -- 
Male 56.9 1.37 (1.20 – 1.57) <0.0001 22.1 1.14 (0.98- 1.32) 0.086 6.1 0.52 (0.39-0.69) <0.0001 
Age 55+ 39.1 Ref. -- 16.9 Ref. -- 5.4 Ref. -- 
40-54 52.7 1.74 (1.49-2.03) <0.0001 22.6 1.33 (1.09-1.66) 0.006 6.8 1.36 (0.94-1.99) 0.106 
25-39 59.9 2.12 (1.83-2.59) <0.0001 25.7 1.45 (1.19-1.77) 0.0002 9.1 1.50 (1.05-2.14) 0.024 
18-24 68.0 2.45 (1.92-3.12) <0.0001 26.7 1.31 (1.03-1.66) 0.026 17.9 1.35 (0.87-2.09) 0.188 
Ethnicity Majority 53.5 Ref. -- 22.7 Ref. -- 8.6 Ref. -- 
Minority 49.7 1.00 (0.82- 1.23) 0.950 21.1 1.02 (0.82-1.28) 0.83 6.1 1.26 (0.83-1.91) 0.278 
Income Low 46.4 Ref. -- 21.2 Ref. -- 10.5 Ref. -- 
Medium 51.9 1.25 (1.04-1.51) 0.014 19.7 0.98 (0.79-1.21) 0.858 6.4 0.79 (0.49-1.27) 0.324 
High 58.9 1.49 (1.24-1.78) <0.0001 25.8 0.96 (0.79-1.18) 0.716 8.4 0.71 (0.43-1.16) 0.167 
No Answer 54.9 1.12 (0.82-1.52) 0.474 19.0 0.70 (0.47-1.04) 0.08 8.2 0.85 (0.39-1.84) 0.685 
Education Low 46.1 Ref. -- 17.5 Ref. -- 6.7 Ref. -- 
Medium 57.7 1.07 (0.92-1.25) 0.373 27.0 1.25 (1.05-1.48) 0.014 9.0 1.21 (0.88-1.66) 0.249 
High 57.9 1.11 (0.91-1.35) 0.290 22.7 1.16 (0.94-1.42) 0.163 10.3 0.98 (0.67-1.44) 0.927 
Smoking 
Status 
Long term Quit 52.7 Ref. -- 31.0 Ref. -- 8.6 Ref. -- 
Recently quit 54.0 0.94 (0.66-1.34) 0.727 23.5 0.70 (0.47-1.04) 0.079 10.8 1.16 (0.63-2.13) 0.635 
Less than daily use 61.6 1.21 (0.86-1.70) 0.277 26.9 0.67 (0.46-0.98) 0.037 10.6 1.13 (0.62-2.06) 0.679 
Daily use 50.3 1.00 (0.73-1.38) 0.986 19.6 0.60 (0.42-0.86) 0.005 6.5 0.99 (0.56-1.73) 0.959 
NVP use 
status 
Never used 39.0 Ref. -- 10.4 Ref. -- 1.1 Ref. -- 
Previously tried 46.9 1.46 (1.19-1.79) 0.0003 16.9 1.62 (1.23-2.12) 0.0005 6.3 4.60 (2.46-8.61) <0.0001 
Quit using 54.2 1.89 (1.52-2.37) <0.0001 18.8 1.47 (1.09-1.98) 0.011 2.7 4.09 (2.07-8.06) <0.0001 
Less than daily user 70.2 2.54 (2.15-3.00) <0.0001 38.6 4.17 (3.44-5.05) <0.0001 11.9 8.79 (5.28-14.65) <0.0001 
Daily user 76.0 4.39 (3.29-5.85) <0.0001 48.6 5.80 (4.43-7.60) <0.0001 37.9 36.2 (20.1-65.0) <0.0001 
*Note: Data are weighted; Bolded estimates are significant at p<0.05; AOR, Odds Ratios adjusted for country, sex, age, ethnicity, income, education, smoking status and NVP status.  
a This analysis excluded individuals who reported having no close friends, ‘don’t know’ or refused to answer (N=1593), resulting in a sample of 9,307 individuals.  
b This analysis excluded individuals who reported not having a partner (N=4,796), resulting in a final sample of 6,106 individuals. 
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Table 3: Logistic regression assessing correlates of societal approval of NVP use , N=10,900 
  
Perception of societal approval of NVP 
use (%) 
 
Society approves of NVP use 
vs. 
Society does not approve 
 
 
I don’t know 
vs. 
Society does not approvea 
  Society 
approves 
Society does 
not approve 
Don’t 
Knowa 
 
AOR (95% CI) 
 
p-value 
 
AOR (95% CI) 
 
p-value 
Country Australia 12.3 56.9 30.7 Ref. -- Ref -- 
 Canada 19.5 67.2 13.4 1.37 (1.02-1.84) 0.038 0.41 (0.33-0.51) <0.0001 
 England 27.6 60.9 11.5 2.10 (1.57-2.82) <0.0001 0.43 (0.34-0.54) <0.0001 
 United States 17.7 64.9 17.4 1.14 (0.83-1.56) 0.417 0.48 (0.38-0.62) <0.0001 
Sex Female 20.3 62.7 17.9 Ref. -- Ref -- 
Male 18.0 65.2 16.8 0.93 (0.81-1.08) 0.349 0.85 (0.72-0.99) 0.043 
Age 55+ 13.3 63.3 23.4 Ref. -- Ref -- 
40-54 17.2 63.9 18.9 1.31 (1.10-1.57) 0.003 0.94 (0.78-1.12) 0.471 
25-39 21.7 65.9 12.4 1.59 (1.32-1.92) <0.0001 0.69 (0.55-0.86) 0.001 
18-24 31.3 61.0 7.7 1.80 (1.43-2.26) <0.0001 0.34 (0.23-0.51) <0.0001 
Ethnicity Majority 18.1 65.1 16.8 Ref. -- Ref -- 
Minority 23.3 59.2 17.5 1.46 (1.18-1.80) 0.0004 1.42 (1.08-1.88) 0.013 
Income Low 21.6 59.1 19.3 Ref. -- Ref -- 
Medium 16.2 67.1 16.7 0.96 (0.80-1.17) 0.737 0.90 (0.72-1.13) 0.365 
High 19.5 66.0 14.5 0.89 (0.74-1.08) 0.086 0.74 (0.59-0.92) 0.009 
No Answer 17.8 59.5 22.7 0.62 (0.44-0.89) 0.009 1.31 (0.93-1.84) 0.128 
Education Low 18.5 59.7 21.8 Ref. -- Ref -- 
Medium 18.6 66.7 14.7 0.81 (0.69-0.95) 0.013 0.79 (0.66-0.94) 0.008 
High 21.5 68.4 10.1 0.84 (0.69-1.02) 0.085 0.68 (0.54-0.85) 0.0008 
Smoking 
Status 
Long Term Quit 15.4 75.6 9.0 Ref. -- Ref -- 
Recently Quit 14.6 71.0 14.3 1.33 (0.90-1.97) 0.149 0.94 (0.57-1.54) 0.806 
Less than daily use 21.5 64.2 14.3 1.43 (0.98-2.09) 0.065 1.05 (0.65-1.70) 0.832 
Daily use 20.7 59.7 19.6 1.92 (1.35-2.75) 0.0003 1.42 (0.91-2.21) 0.124 
NVP use 
status 
Never used 11.9 61.3 26.8 Ref. -- Ref -- 
Previously tried 15.2 69.1 15.7 1.06 (0.82-1.37) 0.656 0.60 (0.46-0.76) <0.0001 
Quit using 18.8 67.1 14.1 1.38 (1.07-1.77) 0.014 0.53 (0.40-0.69) <0.0001 
Less than daily use 27.7 64.4 7.9 1.51 (1.27-1.80) <0.0001 0.38 (0.31-0.47) <0.0001 
Daily user 35.1 57.0 7.9 2.55 (1.99-3.25) <0.0001 0.32 (0.21-0.49) <0.0001 
Note: Data are weighted; Bolded estimates are significant at p<0.05; AOR, Odds Ratios adjusted for country, sex, age, ethnicity, income, education, smoking status and NVP status;  
a I don’t know was retained as a separate category within this model, given the high proportion of individuals that chose this response option. 
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Table 4: Logistic regression assessing correlates of perceptions of approval of NVP use among people important to you, N=10,900 
   
Approval of NVP use among people 
‘important to you’ (%) 
 
People important to you approve 
vs. 
People important to you don’t approve 
 
 
‘I don’t know’ 
vs. 
People important to you don’t approvea 
  Approve of 
NVP use 
Do not approve 
of NVP use 
Don’t 
knowa 
AOR (95% CI) p-value AOR (95% CI) p-value 
Country Australia 14.3 46.3 39.4 Ref. -- Ref. -- 
 Canada 18.1 58.4 23.5 0.97 (0.74-1.27) 0.838 0.55 (0.44-0.69) <0.0001 
 England 28.9 46.0 25.1 1.77 (1.36-2.31) <0.0001 0.81 (0.61-1.09) 0.06 
 United States 18.0 52.7 29.3 0.81 (0.61-1.01) 0.168 0.69 (0.54-0.88) 0.003 
Sex Female 19.0 51.8 29.2 Ref. -- Ref. -- 
Male 19.8 51.8 28.4 0.97 (0.83-1.12) 0.659 0.89 (0.77-1.01) 0.08 
Age 55+ 16.5 44.2 39.3 Ref. -- Ref. -- 
40-54 21.0 47.2 31.8 0.97 (0.81-1.16) 0.746 0.77 (0.66-0.91) 0.002 
25-39 18.4 59.7 21.9 0.84 (0.69-1.02) 0.075 0.54 (0.45-0.65) <0.0001 
18-24 26.3 59.9 13.8 0.78 (0.61-1.00) 0.04 0.35 (0.27-0.45) <0.0001 
Ethnicity Majority 19.6 50.7 29.7 Ref. -- Ref. -- 
Minority 18.5 57.0 24.5 1.07 (0.84-1.36) 0.595 0.87 (0.70-1.08) 0.205 
Income Low 21.3 46.4 32.3 Ref. -- Ref. -- 
Medium 17.6 53.5 28.9 0.87 (0.71-1.07) 0.191 0.83 (0.68-1.00) 0.052 
High 19.4 54.9 25.7 0.73 (0.60-0.90) 0.003 0.78 (0.64-0.95) 0.009 
No Answer 21.1 50.2 28.7 0.72 (0.5-1.04) 0.08 1.11 (0.81-1.52) 0.508 
Education Low 20.7 46.7 32.6 Ref. -- Ref. -- 
Medium 18.1 55.1 26.8 0.68 (0.57-0.80) <0.0001 0.82 (0.70-0.96) 0.011 
High 19.5 56.3 24.2 0.68 (0.56-0.84) 0.0003 0.78 (0.64-0.95) 0.015 
Smoking 
Status 
Long Term Quit 22.9 60.6 16.5 Ref. -- Ref. -- 
Recently Quit 15.2 60.9 23.9 1.13 (0.77-1.66) 0.522 1.36 (0.86-2.14) 0.191 
Less than daily use 15.2 63.4 21.4 0.95 (0.65-1.38) 0.781 1.77 (1.14-2.75) 0.01 
Daily use 21.6 44.2 34.2 2.06 (1.45-2.92) <0.0001 2.66 (1.75-4.04) <0.0001 
NVP use 
status 
Never used 8.7 48.9 42.4 Ref. -- Ref. -- 
Previously tried 13.8 59.6 26.6 1.40 (1.07-1.82) 0.014 0.69 (0.56-0.86) 0.0008 
Quit using 19.0 52.9 28.1 2.19 (1.69-2.86) <0.0001 0.65 ( 0.52-0.81) 0.0001 
Less than daily use 26.2 55.2 18.6 2.29 (1.88-2.78) <0.0001 0.47 (0.40-0.56) <0.0001 
Daily use 59.4 34.2 6.4 9.59 (7.39-12.5) <0.0001 0.18 (0.12-0.27) <0.0001 
Note: Data are weighted; Bolded estimates are significant at p<0.05; AOR, Odds Ratios adjusted for country, sex, age, ethnicity, income, education, smoking status and NVP status.  
a I don’t know was retained as a separate category within this model, given the high proportion of individuals that chose this response option. 
